CIP
ANIP icon

Chartwell Investment Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Chartwell Investment Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$555K Buy
9,301
+75
+0.8% +$4.58K 0.02% 392
2024
Q2 		$587K Sell
9,226
-1,500
-14% -$97.4K 0.02% 385
2024
Q1 		$742K Buy
10,726
+254
+2% +$15.3K 0.03% 387
2023
Q4 		$578K Buy
10,472
+4,641
+80% +$256K 0.02% 396
2023
Q3 		$339K Buy
+5,831
New +$337K 0.01% 405

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Chartwell Investment Partners's ANIP Position: Q3 2024 in Review

Chartwell Investment Partners increased its ANI Pharmaceuticals (ANIP) stake by 0.81% in Q3 2024, buying an estimated $4.58K and bringing the position to 9,301 shares worth $555K. The position accounts for 0.02% of the portfolio, ranked #392.

Chartwell Investment Partners first reported a position in ANIP in Q3 2023 and has held it in 5 quarters since. The position peaked at $742K in Q1 2024. 208 funds tracked by Wall St. Rank hold ANIP as of Q3 2024.

  • Chartwell Investment Partners held 9,301 shares of ANI Pharmaceuticals worth $555K as of Q3 2024.
  • Chartwell Investment Partners bought 75 ANI Pharmaceuticals shares in Q3 2024, an estimated $4.58K.
  • ANI Pharmaceuticals made up 0.02% of Chartwell Investment Partners's portfolio in Q3 2024, its #392 holding.
  • Chartwell Investment Partners first reported a position in ANI Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • Chartwell Investment Partners's ANI Pharmaceuticals position peaked at $742K in Q1 2024.
  • 208 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.